Key result
CYP2C9 variants (*1/*3, *2/*3, or *3/*3) were more frequent among highly unstable oral anticoagulation cases than stable controls.
Why the study?
What factors are associated with persistent instability of oral anticoagulant treatment?
Case-Control (n=157)
Yes
What factors are associated with persistent instability of oral anticoagulant treatment?
High intra-individual variability in oral anticoagulation control is multifactorial, with poor patient comprehension and specific CYP2C9 variants playing significant roles.
Answers are grounded in this paper and cite their sources.
CYP2C9 variants may contribute to anticoagulation instability; leaves open whether genotyping improves control in prospective trials.
The factors associated with persistent instability of oral anticoagulant treatment (OAT) were investigated in a case-control study. The most unstable patients from 35 Italian anticoagulation clinics were matched with stable controls, for gender, age and OAT indication. Socio-demographic data, medical history, dietary and life habits, cytochrome P450 CYP2C9 variants, blood cell count, liver and renal functions were investigated. An 'Abbreviated Mental Test' (AMT) and a questionnaire to assess patient compliance to, and comprehension of, OAT indications and mechanisms were administered. An International Normalized Ratio (INR) above 4.5 was more frequently found in cases (n = 77) than controls (n = 80) (12.3% vs. 0.4%; P < 0.0001). The odds ratio for instability was significantly higher for: people who worked versus pensioners, acenocoumarol versus warfarin, and an insufficient score in the AMT and/or in the questionnaire. Cytochrome P450 CYP2C9 variants *1/*3 or *2/*3 or *3/*3 were more frequent among cases than controls (29.9% vs.15.0%; P = 0.042). No differences were observed as regards the other variables. In conclusion, we found that high intra-individual variability in OAT control was multifactorial, but poor OAT comprehension was prevalent.
No takes yet. Share an insight, caveat, or question.
Palareti et al. (2005) conducted a case-control in Oral anticoagulation instability (n=157). Risk factors (working status, acenocoumarol, poor comprehension, CYP2C9 variants) vs. Stable controls was evaluated on International Normalized Ratio (INR) above 4.5 (p=<0.0001). CYP2C9 variants (*1/*3, *2/*3, or *3/*3) were more frequent among highly unstable oral anticoagulation cases than stable controls.
Synapse has enriched 10 related papers. Consider them for comparative context: